{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:17:26Z","timestamp":1787771846422,"version":"build-2784847793"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Due to the importance of sudden sensorineural hearing loss (SSNHL) and the possible role of blood coagulation in its mechanism and the likely therapeutic effect of anticoagulants and also the lack of studies in this field, this study aimed to evaluate the effect of rivaroxaban (RXA) in the treatment of this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The present double-blind randomized clinical trial study was performed on 34 patients with SSNHL. Patients were randomly divided into two groups. In the first group, in addition to corticosteroid therapy (CST), RXA 10 mg tablets were used daily for 10 days (RXA group), and in the second group, only CST (CST group) treatment was prescribed. Hearing recovery was then assessed and recorded according to the American Academy of Otolaryngology\u2013Head and Neck Surgery (AAO-HNS) criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      This study showed that the grade of hearing recovery in the RXA group (58.8%) was higher than the CST group (47.1%), but this difference was not significant (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &gt;0.05). Also, RXA treatment increased the odds of hearing recovery, and this difference was not statistically significant (odd ratio (95% confidence interval)(OR (95% CI): 2.327 (0.180\u201318.082);\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value = 0.518). In contrast, delay to treatment, more increased PTA (pure tone average (PTA)), and having vertigo reduced the odds of hearing recovery by 0.138-, 0.019-, and 0.069-fold, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt;0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>According to the results of this study, although the percentage of hearing recovery was higher in the RXA group, in general, the results of the two treatments were not significantly different.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/abr.abr_143_23","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T03:00:07Z","timestamp":1706670007000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Rivaroxaban in the Complementary Therapy of Sudden Sensorineural Hearing Loss"],"prefix":"10.4103","volume":"13","author":[{"given":"Mehrdad","family":"Rogha","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Moshtaghi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.joto.2019.07.001","article-title":"Sudden sensorineural hearing loss - A contemporary review of management issues","volume":"15","author":"Singh","year":"2020","journal-title":"J Otol"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"102327","DOI":"10.1016\/j.amjoto.2019.102327","article-title":"Investigation of vitamin D levels in patients with sudden sensory-neural hearing loss and its effect on treatment","volume":"41","author":"Ghazavi","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"917","DOI":"10.15585\/mmwr.mm6534e3","article-title":"Hearing loss in infants with microcephaly and evidence of congenital zika virus infection-Brazil, November 2015-May 2016","volume":"65","author":"Leal","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00405-019-05312-z","article-title":"The prevalence of hearing loss and use of hearing aids among adults in Germany:A systematic review","volume":"276","author":"L\u00f6hler","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R5-20240830","first-page":"385","article-title":"Vestibular Infant Screening-Flanders:What is the most appropriate vestibular screening tool in hearing-impaired children?Ear Hear","volume":"44","author":"Martens","year":"2023"},{"key":"R6-20240830","first-page":"699","article-title":"Hereditary bilateral sudden sensorineural hearing loss","volume":"120","author":"Varga","year":"2019","journal-title":"Bratisl Lek Listy"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaoto.2020.0047","article-title":"Intratympanic vs systemic corticosteroids in first-line treatment of idiopathic sudden sensorineural hearing loss:A systematic review and meta-analysis","volume":"146","author":"Mirian","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/00016489.2019.1614222","article-title":"Intratympanic steroids for combined treatment of idiopathic sudden hearing loss:When is it too late?","volume":"139","author":"Amarillo","year":"2019","journal-title":"Acta Otolaryngol"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/14992027.2019.1689432","article-title":"Contemporary review of the causes and differential diagnosis of sudden sensorineural hearing loss","volume":"59","author":"Young","year":"2020","journal-title":"Int J Audiol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/lary.28231","article-title":"Heparin therapy as adjuvant treatment for profound idiopathic sudden sensorineural hearing loss","volume":"130","author":"Kim","year":"2020","journal-title":"Laryngoscope"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00016488809125068","article-title":"Diagnostic criteria for sudden deafness, mumps deafness and perilymphatic fistula","volume":"456","author":"Nomura","year":"1988","journal-title":"Acta Otolaryngol Suppl"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/lary.26514","article-title":"Laboratory assessment of sudden sensorineural hearing loss:A case-control study","volume":"127","author":"Fasano","year":"2017","journal-title":"Laryngoscope"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40136-022-00414-5","article-title":"Update on the management of idiopathic sudden sensorineural hearing loss","volume":"10","author":"Schwam","year":"2022","journal-title":"Current Otorhinolaryngology Reports"},{"key":"R14-20240830","first-page":"e29458","article-title":"Sudden sensorineural hearing loss:A review","volume":"14","author":"Tripathi","year":"2022","journal-title":"Cureus"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0196-0709(03)00066-8","article-title":"Role of low-molecular-weight heparins in the treatment of sudden hearing loss","volume":"24","author":"Yue","year":"2003","journal-title":"Am J Otolaryngol"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7874\/kja.2012.16.2.71","article-title":"Combination therapy with systemic steroids, an antiviral agent, anticoagulants, and stellate ganglion block for treatment of sudden sensorineural hearing loss","volume":"16","author":"Park","year":"2012","journal-title":"Korean J Audiol"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"e0221713","DOI":"10.1371\/journal.pone.0221713","article-title":"A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss","volume":"14","author":"Ahmadzai","year":"2019","journal-title":"PLoS One"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"814","DOI":"10.29271\/jcpsp.2019.09.814","article-title":"Oral rivaroxaban in symptomatic deep vein thrombosis","volume":"29","author":"Farhan","year":"2019","journal-title":"J Coll Physicians Surg Pak"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/10408347.2020.1839735","article-title":"Review on characteristics and analytical methods of rivaroxaban","volume":"52","author":"Re\u00e7ber","year":"2022","journal-title":"Crit Rev Anal Chem"},{"key":"R20-20240830","first-page":"83","article-title":"Sodium enoxaparin and venovenous hemofiltration in treating sudden sensorineural hearing loss and tinnitus","volume":"12","author":"Mora","year":"2006","journal-title":"Int Tinnitus J"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1056\/NEJMoa0800374","article-title":"Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty","volume":"358","author":"Eriksson","year":"2008","journal-title":"N Engl J Med"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MAO.0b013e31824b78da","article-title":"Corticosteroid treatment of idiopathic sudden sensorineural hearing loss:Randomized triple-blind placebo-controlled trial","volume":"33","author":"Nosrati-Zarenoe","year":"2012","journal-title":"Otol Neurotol"},{"key":"R23-20240830","first-page":"CD003998","article-title":"Steroids for idiopathic sudden sensorineural hearing loss","volume":"2013","author":"Wei","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"102327","DOI":"10.1016\/j.amjoto.2019.102327","article-title":"Investigation of vitamin d levels in patients with sudden sensory-neural hearing loss and its effect on treatment","volume":"41","author":"Ghazavi","year":"2020","journal-title":"Am J Otolaryngol"},{"issue":"(3 Suppl)","key":"R25-20240830","first-page":"S1","article-title":"Clinical practice guideline:Sudden hearing loss","volume":"146","author":"Stachler","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"108565","DOI":"10.1016\/j.heares.2022.108565","article-title":"Idiopathic sudden sensorineural hearing loss:A critique on corticosteroid therapy","volume":"422","author":"Murray","year":"2022","journal-title":"Hear Res"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7874\/jao.2015.19.2.104","article-title":"Persistent positional vertigo in a patient with sudden sensorineural hearing loss:A case report","volume":"19","author":"Kim","year":"2015","journal-title":"J Audiol Otol"},{"key":"R28-20240830","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.otc.2008.01.009","article-title":"Sudden hearing loss","volume":"41","author":"O'Malley","year":"2008","journal-title":"Otolaryngol Clin North Am"},{"key":"R29-20240830","first-page":"488","article-title":"Sudden hearing loss:Circulatory","volume":"5","author":"Fisch","year":"1984","journal-title":"Am J Otol"},{"key":"R30-20240830","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0001-6519(01)78250-7","article-title":"[Non-interventional study on blood filterability changes in the clinical onset of sensorineural sudden deafness","volume":"52","author":"Garc\u00eda Callejo","year":"2001","journal-title":"Acta Otorrinolaringol Esp"},{"key":"R31-20240830","first-page":"256","article-title":"Low molecular weight heparins\u2014A safer option than unfractionated heparin?","volume":"20","author":"McKay","year":"2001","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"R32-20240830","doi-asserted-by":"crossref","first-page":"e11384","DOI":"10.1097\/MD.0000000000011384","article-title":"Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer:A meta-analysis","volume":"97","author":"Xing","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R33-20240830","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1078155217739683","article-title":"Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center:A pilot study","volume":"25","author":"Signorelli","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"R34-20240830","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/mhn.2003.50","article-title":"Diagnosis and treatment of sudden-onset sensorineural hearing loss:A study of 51 patients","volume":"128","author":"Zadeh","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R35-20240830","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/003655402_000028037","article-title":"Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy:A pilot study","volume":"122","author":"Lefebvre","year":"2002","journal-title":"Acta Otolaryngol"},{"key":"R36-20240830","first-page":"1","article-title":"Efficacy of Intratympanic Steroid Injection in Resistant Sudden Sensorineural Hearing Loss with Failure of Systemic Therapy","volume":"27","author":"Hashemi","year":"2009","journal-title":"J Isfahan Med Sch"}],"container-title":["Advanced Biomedical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_143_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:17:29Z","timestamp":1787768249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/abr.abr_143_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":36,"URL":"https:\/\/doi.org\/10.4103\/abr.abr_143_23","relation":{},"ISSN":["2277-9175"],"issn-type":[{"value":"2277-9175","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2023-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}